Shares of HIVE Blockchain Technologies Ltd. (CVE:HIV – Get Free Report) have been assigned a consensus rating of “Strong Buy” from the five analysts that are covering the stock, Marketbeat.com reports. Five equities research analysts have rated the stock with a strong buy recommendation.
A number of analysts have issued reports on the company. Rosenblatt Securities raised HIVE Blockchain Technologies to a “strong-buy” rating in a report on Friday, March 7th. Keefe, Bruyette & Woods upgraded shares of HIVE Blockchain Technologies to a “moderate buy” rating in a research note on Wednesday, January 8th. Finally, Roth Capital upgraded HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Wednesday, December 18th.
View Our Latest Stock Report on HIVE Blockchain Technologies
HIVE Blockchain Technologies Stock Performance
HIVE Blockchain Technologies Ltd. is a business services company in the Business Services industry.
See Also
- Five stocks we like better than HIVE Blockchain Technologies
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- Retail Stocks Investing, Explained
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
